"Merger: main developments between 1 January and 30 April 2010" On 11 February the Commission approved the proposed acquisition of Solvay Pharma (Belgium) by Abbott Laboratories (USA). The decision is conditional upon the divestment of the Cystic Fibrosis testing business of Solvay Pharma’s
The EU Commission conditionally clears the acquisition of a Belgian pharmaceuticals company by a US competitor (Abbott / Solvay Pharmaceuticals)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.